[HTML][HTML] Paclitaxel and docetaxel resistance in prostate cancer: Molecular mechanisms and possible therapeutic strategies

M Hashemi, MA Zandieh, Y Talebi… - Biomedicine & …, 2023 - Elsevier
Prostate cancer is among most malignant tumors around the world and this urological tumor
can be developed as result of genomic mutations and their accumulation during progression …

Chitosan-based advanced materials for docetaxel and paclitaxel delivery: Recent advances and future directions in cancer theranostics

M Ashrafizadeh, Z Ahmadi, N Mohamadi… - International journal of …, 2020 - Elsevier
Paclitaxel (PTX) and docetaxel (DTX) are key members of taxanes with high anti-tumor
activity against various cancer cells. These chemotherapeutic agents suffer from a number of …

Multifunctional nanoparticles codelivering doxorubicin and amorphous calcium carbonate preloaded with indocyanine green for enhanced chemo-photothermal …

J Yu, L Wang, X Xie, W Zhu, Z Lei, L Lv… - International Journal …, 2023 - Taylor & Francis
Background Multifunctional stimuli-responsive nanoparticles with photothermal-
chemotherapy provided a powerful tool for improving the accuracy and efficiency in the …

Targeted nanomedicine modalities for prostate cancer treatment

L Cohen, YD Livney, YG Assaraf - Drug Resistance Updates, 2021 - Elsevier
Prostate cancer (PC) is the second most common cause of death amongst men in the USA.
Therapy of PC has been transformed in the past decade by introducing novel therapeutics …

Combinatorial approaches of nanotherapeutics for inflammatory pathway targeted therapy of prostate cancer

RP Johnson, CK Ratnacaram, L Kumar, J Jose - Drug Resistance Updates, 2022 - Elsevier
Prostate cancer (PC) is the most prevalent male urogenital cancer worldwide. PC patients
presenting an advanced or metastatic cancer succumb to the disease, even after therapeutic …

Peptide-chitosan engineered scaffolds for biomedical applications

N Kulkarni, SD Shinde, GS Jadhav… - Bioconjugate …, 2021 - ACS Publications
Peptides are signaling epitopes that control many vital biological events. Increased
specificity, synthetic feasibility with concomitant lack of toxicity, and immunogenicity make …

Chitosan modified by organo-functionalities as an efficient nanoplatform for anti-cancer drug delivery process

S Jaiswal, PK Dutta, S Kumar, R Chawla - Journal of Drug Delivery Science …, 2021 - Elsevier
Cancer, one of the lethal threats to human health, is most frequently treated with surgery,
chemotherapy and radiation. Specific receptors and abnormal physiochemical conditions …

[HTML][HTML] Protease-triggered bioresponsive drug delivery for the targeted theranostics of malignancy

Y Li, C Zhang, G Li, G Deng, H Zhang, Y Sun… - … Pharmaceutica Sinica B, 2021 - Elsevier
Proteases have a fundamental role in maintaining physiological homeostasis, but their
dysregulation results in severe activity imbalance and pathological conditions, including …

ROS-responsive glycol chitosan-linked prodrug nanoparticle as a nanoplatform for tumor chemo-photodynamic therapy

J Yu, M Liu, C Zhang, L Cheng, C Peng… - Pharmaceutical …, 2024 - Taylor & Francis
Herein, we designed and synthesized novel reactive oxygen species (ROS)-responsive
glycol chitosan-doxorubicin (DOX) prodrug via a ROS-cleavable thioketal (TK) linker. The …

Chitosan-based drug delivery systems in cancer therapeutics

S Padhi, A Behera, MS Hasnain, AK Nayak - Chitosan in Drug Delivery, 2022 - Elsevier
To achieve a fine balance between the onset of therapeutic efficacy and the incidence of
side effects, various drug delivery systems have been intelligently fabricated to achieve …